Recurring Meeting of Cleveland Clinic Core Team

Date: March 22, 2016

Time: 10:30 AM EST

Means: In person meeting

Attendees:

1. Ahmet Erdemir
2. Craig Bennetts
3. Snehal Chokhandre

Agenda:

1. Discuss immediate action items from the last meeting.
2. Continue evaluation of drafts for data manuscripts.
3. Discuss progress of tissue testing protocol evaluation.
4. Decide immediate action items for the next meeting.
5. Other.

Immediate Action Items:

• Craig
  • Continue working on recommendations discussed in the meeting for the imaging manuscript.
  • Document resampling of cartilage surface geometry in the geometry generation specifications page.
  • Start geometry generation of other tissues and document in the geometry generation specifications page.
  • Analyze contact pressure data files to pinpoint sensor orientation.
• Snehal
  • Continue with tissues testing evaluation protocols (next two weeks).
  • Continue providing quantitative information in conclusions sections of tissue testing evaluation page.
• Jason
  • Provide the background for the patellofemoral joint testing manuscript.
• Robb
  • Work with Craig for generation of aggregated contact pressure plots for patellofemoral joint manuscript.
  • Complete the first draft of the patellofemoral joint testing manuscript.
• Tara
  • Continue working on tables for the tibiofemoral joint testing manuscript.

Ongoing Action Items:

DEADLINE FOR SECOND DRAFT DATA PAPERS IS APRIL 1, 2016

• Ahmet
  • Prepare flowcharts to describe data flow for pre-processing of joint kinematics/kinetics data.
• Craig
  • Anatomical imaging manuscript.
  • Large-scale analysis of simulation parameters for convergence.
• Snehal
  • Add citations and summaries to tissue data papers to the wiki for potential use to model tissue properties.
  • Pivot shift manuscript.

  • Cruciate ligament modeling & simulation.

• Robb
  • Patellofemoral joint experimentation manuscript.
• Tara
  • Tibiofemoral joint experimentation manuscript.

Notes:

1. Discuss immediate action items from the last meeting.
   • TBD
2. Continue evaluation of drafts for data manuscripts.
   • TBD
3. Discuss progress of tissue testing protocol evaluation.
   • TBD
4. Decide immediate action items for the next meeting.
   • TBD
5. Other.
   • TBD